Take note of this important date for Genentech: Feb 23. That’s when the Food and Drug Administration is expected to issue its approval decision on Avastin as a treatment for metastatic breast cancer. Read full article below.
Take note of this important date for Genentech: Feb 23. That’s when the Food and Drug Administration is expected to issue its approval decision on Avastin as a treatment for metastatic breast cancer. Read full article below.
